X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (677) 677
index medicus (466) 466
anti-neutrophil cytoplasmic antibody-associated vasculitis - drug therapy (451) 451
female (353) 353
male (312) 312
vasculitis (292) 292
middle aged (259) 259
aged (251) 251
immunosuppressive agents - therapeutic use (248) 248
rheumatology (222) 222
rituximab (213) 213
wegeners-granulomatosis (210) 210
treatment outcome (194) 194
anti-neutrophil cytoplasmic antibody-associated vasculitis - immunology (182) 182
adult (179) 179
anti-neutrophil cytoplasmic antibody-associated vasculitis - diagnosis (176) 176
anca-associated vasculitis (164) 164
cyclophosphamide (158) 158
anti-neutrophil cytoplasmic antibody-associated vasculitis - complications (151) 151
microscopic polyangiitis (135) 135
cyclophosphamide - therapeutic use (130) 130
antibody-associated vasculitis (128) 128
remission induction (124) 124
urology & nephrology (118) 118
antibodies, monoclonal, murine-derived - therapeutic use (109) 109
retrospective studies (99) 99
antibodies, antineutrophil cytoplasmic - blood (97) 97
glomerulonephritis (94) 94
systemic vasculitis (94) 94
drug therapy, combination (93) 93
anca (92) 92
randomized-trial (91) 91
therapy (86) 86
glucocorticoids - therapeutic use (84) 84
disease (83) 83
recurrence (81) 81
antineutrophil cytoplasmic antibodies (80) 80
medicine, general & internal (78) 78
remission (78) 78
risk factors (75) 75
autoantibodies (74) 74
abridged index medicus (73) 73
anti-neutrophil cytoplasmic antibody-associated vasculitis - pathology (73) 73
granulomatosis with polyangiitis (72) 72
immunologic factors - therapeutic use (71) 71
immunosuppressive agents - adverse effects (68) 68
aged, 80 and over (65) 65
care and treatment (65) 65
renal vasculitis (64) 64
antibodies (63) 63
prognosis (63) 63
severity of illness index (62) 62
anti-neutrophil cytoplasmic antibody-associated vasculitis - blood (61) 61
anti-neutrophil cytoplasmic antibody-associated vasculitis - therapy (59) 59
neutrophils (59) 59
biopsy (58) 58
azathioprine - therapeutic use (57) 57
young adult (57) 57
peroxidase - immunology (56) 56
rituximab - therapeutic use (55) 55
churg-strauss-syndrome (54) 54
adolescent (53) 53
granulomatosis with polyangiitis - drug therapy (53) 53
time factors (51) 51
antibodies, antineutrophil cytoplasmic - immunology (50) 50
biomarkers - blood (50) 50
small-vessel vasculitis (50) 50
immunosuppressive agents - administration & dosage (48) 48
patients (48) 48
adrenal cortex hormones - therapeutic use (47) 47
anti-neutrophil cytoplasmic antibody-associated vasculitis - mortality (47) 47
glomerulonephritis - drug therapy (47) 47
term-follow-up (47) 47
immunology (46) 46
medicine & public health (46) 46
granulomatosis (45) 45
animals (44) 44
viral antibodies (44) 44
classification (43) 43
mortality (43) 43
research (43) 43
rheumatoid-arthritis (43) 43
anti-neutrophil cytoplasmic antibody-associated vasculitis - chemically induced (42) 42
health aspects (42) 42
disease progression (41) 41
maintenance therapy (40) 40
nephrology (39) 39
diagnosis (38) 38
follow-up studies (38) 38
glomerulonephritis - immunology (38) 38
randomized controlled trials as topic (38) 38
relapse (38) 38
maintenance (37) 37
analysis (36) 36
anti-neutrophil cytoplasmic antibody-associated vasculitis - physiopathology (36) 36
antibodies, monoclonal, murine-derived - adverse effects (36) 36
systemic-lupus-erythematosus (35) 35
anti-neutrophil cytoplasmic antibody (34) 34
diagnosis, differential (34) 34
cyclophosphamide - adverse effects (33) 33
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (634) 634
German (18) 18
Spanish (12) 12
French (10) 10
Japanese (10) 10
Italian (9) 9
Croatian (2) 2
Danish (2) 2
Polish (2) 2
Russian (2) 2
Finnish (1) 1
Hungarian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 5, pp. 417 - 427
This study of ANCA-associated vasculitis compared a single course of rituximab with conventional immunosuppression with cyclophosphamide followed by... 
WEGENERS-GRANULOMATOSIS | MAINTENANCE | MEDICINE, GENERAL & INTERNAL | ANTIBODY-ASSOCIATED VASCULITIS | RENAL VASCULITIS | CYCLOPHOSPHAMIDE | RITUXIMAB | ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES | RANDOMIZED-TRIAL | SYSTEMIC VASCULITIDES | CELL-ACTIVATION | Recurrence | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Double-Blind Method | Drug Administration Schedule | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Immunologic Factors - administration & dosage | Kaplan-Meier Estimate | B-Lymphocytes | Rituximab | Cyclophosphamide - adverse effects | Remission Induction | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Cyclophosphamide - therapeutic use | Immunosuppressive Agents - adverse effects | Immunologic Factors - adverse effects | Drug Therapy, Combination | Antibodies, Monoclonal, Murine-Derived - adverse effects | Azathioprine - adverse effects | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Immunologic Factors - therapeutic use | Immunosuppression | Vasculitis | Drug therapy | Patient outcomes | Disease | Medical treatment | Hypersensitivity | Patients | Immunosuppressive agents | Cyclophosphamide | Infectious diseases | Lymphocytes B | Antineutrophil cytoplasmic antibodies | Remission | Azathioprine
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2016, Volume 75, Issue 6, pp. 1166 - 1169
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2014, Volume 371, Issue 19, pp. 1771 - 1780
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2010, Volume 363, Issue 3, pp. 211 - 220
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 09/2016, Volume 75, Issue 9, pp. 1583 - 1594
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 07/2017, Volume 69, Issue 7, pp. 1470 - 1479
Journal Article
9.